JGCHEM — JG Chemicals Balance Sheet
0.000.00%
- IN₹14.49bn
- IN₹13.00bn
- IN₹8.48bn
- 74
- 27
- 56
- 53
Annual balance sheet for JG Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | Interim Report | Interim Report | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 103 | 170 | 260 | 1,749 | 1,350 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,163 | 1,180 | 1,260 | 1,557 | 1,847 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,756 | 2,237 | 2,563 | 3,939 | 4,440 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 224 | 297 | 362 | 417 | 400 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,099 | 2,641 | 2,978 | 4,490 | 4,979 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 850 | 1,017 | 767 | 395 | 223 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,015 | 1,115 | 901 | 506 | 332 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,085 | 1,526 | 2,077 | 3,984 | 4,648 |
| Total Liabilities & Shareholders' Equity | 2,099 | 2,641 | 2,978 | 4,490 | 4,979 |
| Total Common Shares Outstanding |